G C-H Koh1, B C Tai, L-W Ang, D Heng, J-M Yuan, W-P Koh. 1. Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Block MD3, #03-20, 16 Medical Drive, 117597 Singapore, Singapore. Gerald_Koh@nuhs.edu.sg
Abstract
UNLABELLED: All-cause mortality risk persisted for 5 years after hip fractures in both men and women. There may be gender-specific differences in effect and duration of excess risk for cause-specific mortality after hip fracture. INTRODUCTION: To determine all-cause and cause-specific mortality risk in the first 5 years after hip fracture in an Asian Chinese population. METHODS: The Singapore Chinese Health Study is a population-based cohort of 63,257 middle-aged and elderly Chinese men and women in Singapore recruited between 1993 and 1998. This cohort was followed up for hip fracture and death via linkage with nationwide hospital discharge database and death registry. As of 31 December 2008, we identified 1,166 hip fracture cases and matched five non-fracture cohort subjects by age and gender for each fracture case. Cox proportional hazards and competing risks regression models with hip fracture as a time-dependent covariate were used to determine all-cause and cause-specific mortality risk, respectively. RESULTS: Increase in all-cause mortality risk persisted till 5 years after hip fracture (adjusted hazard ratio, aHR = 1.58 [95 % CI, 1.35-1.86] for females and aHR = 1.64 [95 % CI, 1.30-2.06] for males). Men had higher mortality risk after hip fracture than women for deaths from stroke and cancer up to 1 year post-fracture but women with hip fracture had higher coronary artery mortality risk than men for 5 years post-fracture. Men had higher risk of death from pneumonia while women had increased risk of death from urinary tract infections. There was no difference in mortality risk by types of hip fracture surgery. CONCLUSIONS: All-cause mortality risk persisted for 5 years after hip fractures in men and women. There are gender-specific differences in effect size and duration of excess mortality risk from hip fractures between specific causes of death.
UNLABELLED: All-cause mortality risk persisted for 5 years after hip fractures in both men and women. There may be gender-specific differences in effect and duration of excess risk for cause-specific mortality after hip fracture. INTRODUCTION: To determine all-cause and cause-specific mortality risk in the first 5 years after hip fracture in an Asian Chinese population. METHODS: The Singapore Chinese Health Study is a population-based cohort of 63,257 middle-aged and elderly Chinese men and women in Singapore recruited between 1993 and 1998. This cohort was followed up for hip fracture and death via linkage with nationwide hospital discharge database and death registry. As of 31 December 2008, we identified 1,166 hip fracture cases and matched five non-fracture cohort subjects by age and gender for each fracture case. Cox proportional hazards and competing risks regression models with hip fracture as a time-dependent covariate were used to determine all-cause and cause-specific mortality risk, respectively. RESULTS: Increase in all-cause mortality risk persisted till 5 years after hip fracture (adjusted hazard ratio, aHR = 1.58 [95 % CI, 1.35-1.86] for females and aHR = 1.64 [95 % CI, 1.30-2.06] for males). Men had higher mortality risk after hip fracture than women for deaths from stroke and cancer up to 1 year post-fracture but women with hip fracture had higher coronary artery mortality risk than men for 5 years post-fracture. Men had higher risk of death from pneumonia while women had increased risk of death from urinary tract infections. There was no difference in mortality risk by types of hip fracture surgery. CONCLUSIONS: All-cause mortality risk persisted for 5 years after hip fractures in men and women. There are gender-specific differences in effect size and duration of excess mortality risk from hip fractures between specific causes of death.
Authors: S Kitamura; Y Hasegawa; S Suzuki; R Sasaki; H Iwata; H Wingstrand; K G Thorngren Journal: Clin Orthop Relat Res Date: 1998-03 Impact factor: 4.176
Authors: T B Harris; L Ferrucci; R P Tracy; M C Corti; S Wacholder; W H Ettinger; H Heimovitz; H J Cohen; R Wallace Journal: Am J Med Date: 1999-05 Impact factor: 4.965
Authors: L Joseph Melton; Elizabeth J Atkinson; Jennifer L St Sauver; Sara J Achenbach; Terry M Therneau; Walter A Rocca; Shreyasee Amin Journal: J Bone Miner Res Date: 2014-07 Impact factor: 6.741
Authors: O Wang; Y Hu; S Gong; Q Xue; Z Deng; L Wang; H Liu; H Tang; X Guo; J Chen; X Jia; Y Xu; L Lan; C Lei; H Dong; G Yuan; Q Fu; Y Wei; W Xia; L Xu Journal: Osteoporos Int Date: 2015-05-13 Impact factor: 4.507
Authors: M von Friesendorff; F E McGuigan; A Wizert; C Rogmark; A H Holmberg; A D Woolf; K Akesson Journal: Osteoporos Int Date: 2016-05-12 Impact factor: 4.507
Authors: M Iki; Y Fujita; J Tamaki; K Kouda; A Yura; Y Sato; J S Moon; A Harano; K Hazaki; E Kajita; M Hamada; K Arai; K Tomioka; N Okamoto; N Kurumatani Journal: Osteoporos Int Date: 2016-10-18 Impact factor: 4.507